VIP neurotrophism in the central nervous system: Multiple effecters and identification of a femtomolar-acting neuroprotective peptide

Annals of the New York Academy of Sciences

Volumn 865, Issue , 1998, Pages 207-212

  Brenneman, Douglas E ^a   Glazner, Gordon ^a   Hill, Joanna M ^a   Hauser, Janet ^a   Davidson, Ariane ^b   Gozes, Illana ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ANTISERUM; CYTOKINE; GLYCOPROTEIN GP 120; HEAT SHOCK PROTEIN 60; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; N METHYL DEXTRO ASPARTIC ACID; NEUROTROPHIC FACTOR; PROTEASE NEXIN I; VASOACTIVE INTESTINAL POLYPEPTIDE;

APOPTOSIS; CELL DEATH; CONFERENCE PAPER; DEGENERATIVE DISEASE; GLIA; GROWTH REGULATION; HUMAN IMMUNODEFICIENCY VIRUS; NERVE CELL NECROSIS; NERVE GROWTH; NEUROPROTECTION; NEUROTROPISM;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0032430335     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb11180.x     Document Type: Conference Paper

References (24)

1. Waschek, J. A. 1995. Vasoactive intestinal peptide: an important trophic factor and developmental regulator. Dev. Neurosci. 17: 1-7 (abstract).
2. Gozes, I. & D. E. Brenneman. 1989. VIP: molecular biology and neurobiological function. Mol. Neurobiol. 3: 201-236.
3. Gressens, P., J. M. Hill, I. Gozes, M. Fridkin & D. E. Brenneman. 1993. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature 362: 155-158.
4. Pincus, D. W., E. DiCicco-Bloom & I. B. Black. 1994. Trophic mechanisms regulate mitotic neuronal precursors: role of vasoactive intestinal peptide (VIP). Brain Res. 663: 51-60.
5. Brenneman, D. E., L. E. Eiden & R. E. Siegel. 1985. Neurotrophic action of VIP on spinal cord cultures. Peptides 6 (Suppl 2): 35-39.
6. Brenneman, D. E. & L. E. Eiden. 1986. Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc. Natl. Acad. Sci. USA 83: 1159-1162.
7. Brenneman, D. E., E. A. Neale, G. A. Foster, S.W. D'Autremont & G. L. Westbrook. 1987. Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide. J. Cell Biol. 104: 1603-1610.
8. Gozes, I., S. K. MCCune, L. Jacobson, D. Warren, T. W. Moody, M. Fridkin & D. E. Brenneman. 1991. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system. J. Pharmacol. Exp. Ther. 257: 959-966.
9. Fatatis, A., L. A. Holtzclaw, R. Avidor, D. E. Brenneman & J. T. Russell. 1994. Vasoactive intestinal peptide increases intracellular calcium in astroglia: synergism with alpha-adrenergic receptors. Proc. Natl. Acad. Sci. USA 91: 2036-2040.
10. Olah, Z., C. Lehel, W. B. Anderson, D. E. Brenneman & D. Van Agoston. 1994. Subnanomolar concentration of VIP induces the nuclear translocation of protein kinase C in neonatal rat cortical astrocytes. J. Neurosci. Res. 39: 355-363.
11. Schettini, G., M. Grimaldi, P. Navarra, G. Pozzoli, S. Reichlin & P. Preziosi. 1994. Regulation of interleukin 6 production by cAMP-protein kinase-A pathway in rat cortical astrocytes. Pharmacol. Res. 30: 13-24.
12. Arimura, A., A. Somogyvari-Vigh, C. Weill, R. C. Fiore, I. Tatsuno, V. Bay & D. E. Brenneman. 1994. PACAP functions as a neurotrophic factor. Ann. N. Y. Acad. Sci. 739: 228-243.
13. Brenneman, D. E., J. M. Hill, G. W. Glazner, I. Gozes & T. W. Phillips. 1995. Interleukin-1 alpha and vasoactive intestinal peptide: enigmatic regulation of neuronal survival. Int. J. Dev. Neurosci. 13: 187-200.
14. Brenneman, D. E., M. Schultzberg, T. Bartfai & I. Gozes. 1992. Cytokine regulation of neuronal survival. J. Neurochem. 58: 454-460.
15. Brenneman, D. E. & I. Gozes. 1996. A femtomolar-acting neuroprotective peptide [see comments]. J. Clin. Invest. 97: 2299-2307.
16. Festoff, B. W., J. B. Nelson & D. E. Brenneman. 1996. Prevention of activity-dependent neuronal death: vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombininhibiting neurotrophic serpin, protease nexin-I. J. Neurobiol. 30: 255-266. (abstract)
17. Monard, D., E. Niday, A. Limat & F. Solomon. 1983. Inhibition of protease activity can lead to neurite extension in neuroblastoma cells. Prog. Brain Res. 58: 359-364.
18. Gozes, I. & D. E. Brenneman. 1996. Activity-dependent neurotrophic factor (ADNF). An extracellular neuroprotective chaperonin? J. Mol. Neurosci. 7: 235-244.
19. Gozes, I., A. Davidson, Y. Gozes, R. Mascolo, R. Barth, D. Warren, J. Hauser & D. E. Brenneman. 1997. Antiserum to activity-dependent neurotrophic factor produces neuronal cell death in CNS cultures: immunological and biological specificity. Dev. Brain Res. 99: 167-175.
20. Brenneman, D. E., G. L. Westbrook, S. P. Fitzgerald, D. L. Ennist, K. L. Elkins, M. R. Ruff & C. B. Pert. 1988. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335: 639-642.
21. Gozes, I., A. Bardea, A. Reshef, R. Zamostiano, S. Zhukovsky, S. Rubinraut, M. Fridkin, & D. E. Brenneman. 1996. Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide. Proc. Natl. Acad. Sci. USA 93: 427-432.
22. Mark, R. J., E. M. Blanc & M. P. Mattson. 1996. Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease. Mol. Neurobiol. 12: 211-224.
23. Gressens, P., S. Marret, J. M. Hill, D. E. Brenneman, I. Gozes, M. Fridkin & P. Evrard. 1997. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. J. Clin. Invest. 100: 390-397.
24. Schmechel, D., P. J. Marangos, A. P. Zis, M. Brightman & F. K. Goodwin. 1978. Brain endolases as specific markers of neuronal and glial cells. Science 199: 313-315.